(Total Views: 497)
Posted On: 11/11/2020 4:08:12 PM
Post# of 145247
DVB,
There will not be an alteration of the molecule, IMO. There will be trials demonstrating efficacy in a host of indications, then labeling extensions.
Similar to what has happened with other immune modulating mAbs.
There will not be an alteration of the molecule, IMO. There will be trials demonstrating efficacy in a host of indications, then labeling extensions.
Similar to what has happened with other immune modulating mAbs.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)